CASE REPORT
Giant hamartoma of the nasopharynx – case report
 
More details
Hide details
1
Department of Otolaryngology, Head and Neck Diseases, Clinical University Hospital in Olsztyn, Poland
2
Department of Otolaryngology, Head and Neck Diseases, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Poland
CORRESPONDING AUTHOR
Katarzyna Zasadzińska   

Department of Otolaryngology, Head and Neck Diseases, Clinical University Hospital in Olsztyn, Warszawska 30, 10-082 Olsztyn, Poland,
Submission date: 2018-12-21
Final revision date: 2019-06-18
Acceptance date: 2019-06-18
Online publication date: 2019-12-16
 
Pol. Ann. Med. 2020;27(1):48–52
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Hamartoma is a developmental disorder.

Aim:
The aim of this study is to present a case of hamartoma of naso- and oropharynx and discuss the possible surgical approaches.

Case study:
A a 55-year-old male patient, who had undergone a tracheotomy due to increasing breathing difficulties was admitted to Head and Neck Diseases Clinic in the Clinical University Hospital in Olsztyn with the aim of proceeding further.

Results and discussion:
The parapharyngeal space is divided into the prestyloid and the retrostyloid compartment.Tumours of parapharyngeal space are responsible for 1% of head and neck tumours; 80% of these tumours are benign lesions, most often originating from the parotid gland (50% of all the cases).

Conclusions:
The treatment of choice for benign lesions like the hamartoma is a surgical resection. It is important to choose a suitable surgical approach considering morphotic parameters of a tumour, anatomic and topographic conditions.

CONFLICT OF INTEREST
None.
FUNDING
None.
 
REFERENCES (14)
1.
Ozolek J, Carrau R, Barnes E, Hunt J. Nasal chondrome­senchymal hamartoma in older children and adults: Series and immunohistochemical analysis. Arch Pathol Lab Med. 2005;129(11):1444–1450. https://doi.org/10.1043/1543­-....
 
2.
Fang G, Wang C, Piao Y, Zhang L. Chondro-osseous respi­ratory epithelial adenomatoid hamartoma of the nasal cavi­ty. Pediatr Int. 2016;58(3):229–231. https://doi.org/10.1111/ped.12....
 
3.
Qasem SA, DeYoung BR. Cartilage-forming tumors. Semin Diagn Pathol. 2014;31(1):10–20. https://doi.org/10.1053/j.semd....
 
4.
Markowski J, Gierek T, Świderek M, et al. A case of the respiratory epithelial adenomatoid hamartoma (REAH) of the nasal cavity and paranasal sinuses. Otolaryngologia. 2012;11(1):27–30 [in Polish].
 
5.
Wang T, Li W, Wu X, et al. Nasal chondromesenchymal hamartoma in young children: CT and MRI findings and review of the literature. World J Surg Oncol. 2014;12(1):257. https://dx.doi.org/10.1186%2F1....
 
6.
Obidan A, Ashoor MM. Nasal chondromesenchymal ha­martoma in an adolescent with pleuropulmonary blastoma. Saudi Med J. 2014;35(8):876–878.
 
7.
Dinescu F, Chirilă M, Ţiple C, Cosgarea M. Respiratory chondromesenchymal hamartoma: Case reports and litera­ture review. HVM Bioflux. 2015;7(4):249–252.
 
8.
Gulbinowicz-Gowkielewicz M, Kibiłda B, Gugała K. Pri­mary extracranial meningioma in the form of nasal polyps. Pol Ann Med. 2011;18(Suppl 1):51–52.
 
9.
Waltonen JD. Role of surgery in treatment of head and neck cancer. In: Radosevich J, ed. Head & Neck Cancer: Current Perspectives, Advances, and Challenges. Chicago: Springer. 2013;533–534. https://doi.org/10.1007/978-94....
 
10.
Kumar S, Deka RC, Agarwal JT. Hamartoma of the pha­rynx – A case report. Indian J Otolaryngol. 1991;43(1):30–32. https://doi.org/10.1007/BF0299....
 
11.
Carrau RL, Johnson JT, Myers EN. Management of tu­mors of the parapharyngeal space. Oncology (Williston Park). 1997;11(5):633–640.
 
12.
Janczewski G. [Tu­mors of the parapharyngeal space]. In: Janczewski G. [Practical Otorynolaryngology]. Vol. 2. Gdańsk: Via Medica; 2006;444–448 [in Polish].
 
13.
Abdel-Aziz M. Palatopharyngeal sling: A new technique in treatment of velopharyngeal insufficiency. Int J Pediatr Otor­hinolaryngol. 2008;72(2):173–177. https://doi.org/10.1016/j.ijpo....
 
14.
Stewart DR, Messinger S, Williams G, et al. Nasal chon­dromesenchymal hamartomas arise secondary to germline and somatic mutations of DICER1 in the pleuropulmonary blastoma tumor-predisposition disorder. Hum Genet. 2014; 133(11):1443–1450. https://doi.org/10.1007/s00439....